Cancer Research Horizons

Cancer Research Horizons is the innovation and commercialisation arm of Cancer Research UK and operates as a specialist oncology-focused drug discovery, development and licensing company. It advances cancer therapeutics, diagnostics and data assets by combining in-house translational expertise, a network of researchers and clinicians, and partnerships with biotechnology, pharmaceutical and investor groups. The organization supports projects from early discovery through clinical development, while also creating and backing spinout companies and licensing intellectual property. Its portfolio spans small molecules, antibodies, cell therapies, vaccines, radiopharmaceuticals and oncology datasets. Cancer Research Horizons has contributed to multiple marketed products and maintains an active partnered pipeline across preclinical and clinical oncology programs.